Although elevated MIP-1α is also associated with neurodegenerative pathology, including AD [97], MIP-1α may enhance monocyte differentiation into macrophages and their migration through the blood–brain barrier, which could favor Aβ phagocytosis in the early stages of AD [98]. Here, CCL3 is linked to Alzheimer disease.